デフォルト表紙
市場調査レポート
商品コード
1769694

OTC外用薬の世界市場レポート2025年

Over The Counter (OTC) Topical Drugs Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
OTC外用薬の世界市場レポート2025年
出版日: 2025年07月07日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

OTC外用薬市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率(CAGR)は9.8%で、922億5,000万米ドルに成長します。この成長予測には、オンラインショッピングプラットフォームの利用拡大、軽度の創傷や感染症の発生率の増加、ハーブや植物由来の局所治療薬への関心の高まり、市販の疼痛管理ソリューションの需要急増、デジタルヘルス技術の採用増加などの要因が寄与しています。予測期間中に予想される主な動向には、ドラッグデリバリー技術の革新、製品開発におけるAIの応用、テクノロジーによるテーラーメイドのスキンケアソリューション、皮膚科学における進歩、製品パッケージングや塗布方法の強化などがあります。

皮膚がんの罹患率の上昇は、OTC外用薬(OTC)外用薬市場の成長を促進すると予想されます。異常な皮膚細胞の無秩序な増殖を特徴とする皮膚がんは、通常、太陽や日焼けベッドからの紫外線(UV)放射によって引き起こされます。紫外線への過剰な曝露は皮膚細胞のDNAを損傷し、皮膚がん発症のリスクを高める。OTC外用薬は、治療中の症状や皮膚の炎症に対処する上でサポート的な役割を果たし、処方された治療を補完する身近な緩和手段を提供します。これらの製品は、患部を和らげ、皮膚の回復を促進し、患者の快適性を高める。例えば、オーストラリアを拠点とする政府機関Cancer Australiaによると、2023年には新たに約8,257例の皮膚黒色腫が診断され、これはがん関連死全体の2.6%に相当します。このような有病率の増加が、OTC外用治療に対する需要の拡大に寄与しています。

OTC外用薬市場の主要企業は、かゆみや皮膚の炎症を迅速かつ効果的に緩和する外用抗ヒスタミン薬などの革新的ソリューションの開発を優先しています。皮膚に直接塗布するこれらの薬は、ヒスタミンをブロックすることで作用し、赤みやかゆみ、アレルギー反応を緩和します。例えば、2025年4月、英国のヘルスケア企業Kingsway Pharma Limitedは、トリペレナミン塩酸塩を含有するステロイドフリーの抗ヒスタミンクリーム、Pyribenzamine Over the Counter(PBZ OTC)を発売しました。この製品は、成人および2歳以上の小児の軽微な皮膚の炎症やかゆみを素早く、的を絞って緩和するよう設計されています。べたつかず、素早く吸収される処方で、家庭用救急箱の実用的な選択肢となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のOTC外用薬:PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のOTC外用薬市場:成長率分析
  • 世界のOTC外用薬市場の実績:規模と成長, 2019-2024
  • 世界のOTC外用薬市場の予測:規模と成長, 2024-2029, 2034F
  • 世界のOTC外用薬:総潜在市場規模(TAM)

第6章 市場セグメンテーション

  • 世界のOTC外用薬市場:薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 鎮痛剤
  • 抗生物質
  • 抗真菌剤
  • 鎮痒剤(かゆみ止め)
  • 収斂剤
  • その他の薬物クラス
  • 世界のOTC外用薬市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 痛みの緩和
  • スキンケア
  • 創傷ケア
  • その他の用途
  • 世界のOTC外用薬市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • ドラッグストア
  • 世界のOTC外用薬市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 大人
  • 小児科
  • 老年医学
  • 世界のOTC外用薬市場鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗刺激剤
  • カプサイシンベースのクリーム
  • リドカインベースの製品
  • トロラミンサリチル酸塩製剤
  • 複合鎮痛剤
  • 世界のOTC外用薬市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バシトラシンベースの軟膏
  • ネオマイシンベースのクリーム
  • ポリミキシンBの組み合わせ
  • ムピロシンOTC
  • 消毒薬と抗生物質の組み合わせ
  • 世界のOTC外用薬市場抗真菌剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • クロトリマゾールクリーム
  • ミコナゾールクリーム
  • テルビナフィン製剤
  • トルナフタート系製品
  • ウンデシレン酸外用液
  • 世界のOTC外用薬市場、かゆみ止め薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ヒドロコルチゾンクリーム
  • カラミンローション
  • ジフェンヒドラミン外用ゲル
  • プラモキシンベースの製剤
  • メントールまたはカンフルかゆみ止めローション
  • 世界のOTC外用薬市場収斂剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ウィッチヘーゼルソリューション
  • 酢酸アルミニウム
  • 酸化亜鉛軟膏
  • タンニン酸または植物由来の収れん剤
  • 世界のOTC外用薬市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ニキビ治療外用薬
  • 抗ウイルスクリーム
  • 創傷治癒軟膏
  • 保湿・バリアクリーム

第7章 地域別・国別分析

  • 世界のOTC外用薬市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のOTC外用薬市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • OTC外用薬市場:競合情勢
  • OTC外用薬市場:企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • The Procter And Gamble Company Overview, Products and Services, Strategy and Financial Analysis
    • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Abbott Laboratories
  • Novartis AG
  • GSK plc
  • 3M Company
  • Sun Pharmaceutical Industries Ltd
  • Perrigo Company plc
  • Cipla Limited
  • Zydus Cadila Healthcare Limited
  • Glenmark Pharmaceuticals Limited
  • Mankind Pharma Limited
  • PL Developments Inc.
  • Emami Limited
  • LNK International Inc.
  • Reckitt Benckiser Group plc
  • Trillium Health Care Products Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • OTC外用薬市場2029:新たな機会を提供する国
  • OTC外用薬市場2029:新たな機会を提供するセグメント
  • OTC外用薬市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r36009

Over-the-counter (OTC) topical drugs are medications intended for direct application to the skin or mucous membranes and can be obtained without a prescription. These drugs are primarily used to address minor ailments such as skin irritations, pain, inflammation, infections, or itching. They are generally regarded as safe and effective for public use, offering an accessible and convenient option for managing everyday non-critical health issues.

Key categories of OTC topical drugs include analgesics, antibiotics, antifungals, antipruritics (anti-itch agents), astringents, and others. Analgesics, commonly referred to as pain relievers, are used to reduce pain without causing unconsciousness and function by interrupting pain signals or modifying how the brain interprets pain. These products are utilized across various areas such as pain management, skin treatment, and wound care. Distribution takes place through numerous channels, such as hospital pharmacies, retail pharmacies, online platforms, and drugstores, catering to a broad spectrum of end-users including adults, children, and the elderly.

The over-the-counter topical drugs market research report is one of a series of new reports from The Business Research Company that cover over-the-counter topical drugs market statistics, including the over-the-counter topical drugs industry's global market size, regional shares, competitors with the over-the-counter topical drugs market share, detailed over-the-counter topical drugs market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter topical drugs market. This over-the-counter topical drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The over the counter (OTC) topical drugs market size has grown rapidly in recent years. It will grow from $57.58 billion in 2024 to $63.41 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. This expansion during the historic period has been supported by factors such as the increasing occurrence of skin-related conditions, a growing inclination among consumers for self-treatment, enhanced awareness regarding skincare, a rise in the aging population, and the broader availability of improved drug formulations.

The over the counter (OTC) topical drugs market size is expected to see strong growth in the next few years. It will grow to $92.25 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. Contributing to this projected growth are factors such as the expanding use of online shopping platforms, the growing incidence of minor wounds and infections, rising interest in herbal and plant-based topical remedies, a surge in demand for over-the-counter pain management solutions, and the increasing adoption of digital health technologies. Key trends anticipated in the forecast period include innovation in drug delivery technologies, application of AI in product development, tailored skincare solutions driven by technology, progress in dermatological science, and enhancements in product packaging and application methods.

The rising incidence of skin cancer is anticipated to drive the growth of the over-the-counter (OTC) topical drugs market. Skin cancer, characterized by the uncontrolled growth of abnormal skin cells, is typically caused by ultraviolet (UV) radiation from the sun or tanning beds. Excessive exposure to UV rays damages the DNA in skin cells, increasing the risk of developing skin cancer. OTC topical drugs play a supportive role in managing symptoms and skin irritation during treatment, offering accessible relief options that complement prescribed therapies. These products help soothe affected areas and promote skin recovery, thereby enhancing patient comfort. For example, according to Cancer Australia, an Australia-based government agency, approximately 8,257 new cases of melanoma of the skin were diagnosed in 2023, representing 2.6% of all cancer-related deaths. This growing prevalence is contributing to the expanding demand for OTC topical treatments.

Leading companies in the OTC topical drugs market are prioritizing the development of innovative solutions such as topical antihistamines to provide quick and effective relief from itching and skin irritation. These medications, applied directly to the skin, work by blocking histamine, thereby alleviating redness, itching, and allergic reactions. For instance, in April 2025, Kingsway Pharma Limited, a UK-based healthcare company, introduced Pyribenzamine Over the Counter (PBZ OTC), a steroid-free antihistamine cream containing tripelennamine HCl. The product is designed to deliver fast, targeted relief for minor skin irritations and itching in both adults and children aged two and older. Its non-greasy, fast-absorbing formula makes it a practical choice for household first-aid kits.

In June 2024, Aterian Investment Partners LP, a U.S.-based private equity firm, acquired Contract Pharmaceuticals Limited (CPL) for an undisclosed amount. This strategic move is intended to support CPL's next phase of growth by enhancing its capabilities through investments in personnel, technology, and operational processes. The goal is to deliver greater value to customers and strengthen CPL's leadership in the manufacturing of non-sterile liquid and topical OTC drug products. CPL is a Canada-based contract development and manufacturing organization specializing in the development and commercial production of OTC topical medications.

Major players in the over the counter (otc) topical drugs market are Pfizer Inc., The Procter And Gamble Company, Johnson And Johnson, Bayer AG, Sanofi S.A., Abbott Laboratories, Novartis AG, GSK plc, 3M Company, Sun Pharmaceutical Industries Ltd, Perrigo Company plc, Cipla Limited, Zydus Cadila Healthcare Limited, Glenmark Pharmaceuticals Limited, Mankind Pharma Limited, PL Developments Inc., Emami Limited, LNK International Inc., Reckitt Benckiser Group plc, Trillium Health Care Products Inc., Allegiant Health Corporation, Vivunt Pharma Pvt. Ltd.

North America was the largest region in the over the counter (OTC) topical drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in over the counter (OTC) topical drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the over the counter (OTC) topical drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over the counter (OTC) topical drugs market consists of sales of calamine lotion, topical antiseptics, antiviral creams, anti-itch creams, and wart removal products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over The Counter (OTC) Topical Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over the counter (otc) topical drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for over the counter (otc) topical drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The over the counter (otc) topical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug Class: Analgesics; Antibiotics; Antifungal; Antipruritic (Anti-Itch); Astringents; Other Drug Classes
  • 2) By Application: Pain Relief; Skin Care; Wound Care; Other Applications
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
  • 4) By End-User: Adults; Pediatrics; Geriatrics
  • Subsegments:
  • 1) By Analgesics: Counterirritants; Capsaicin-Based creams; Capsaicin-Based Creams; Lidocaine-Based Products; Trolamine Salicylate Formulations; Combination Analgesics
  • 2) By Antibiotics: Bacitracin-Based Ointments; Neomycin-Based Creams; Polymyxin B Combinations; Mupirocin OTC; Antiseptic-Antibiotic Combinations
  • 3) By Antifungal: Clotrimazole Creams; Miconazole Creams; Terbinafine Formulations; Tolnaftate-Based Products; Undecylenic Acid Topical Solutions
  • 4) By Antipruritic: Hydrocortisone Creams; Calamine Lotion; Diphenhydramine Topical Gels; Pramoxine-Based Formulations; Menthol OR Camphor Anti-Itch Lotions
  • 5) By Astringents: Witch Hazel Solutions; Aluminum Acetate; Zinc Oxide Ointments; Tannic Acid Or Plant-Based Astringents
  • 6) By Other Drug Classes: Acne Treatment Topicals; Antiviral Creams; Wound Healing Ointments; Moisturizing And Barrier Creams
  • Companies Mentioned: Pfizer Inc.; The Procter And Gamble Company; Johnson And Johnson; Bayer AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Over The Counter (OTC) Topical Drugs Market Characteristics

3. Over The Counter (OTC) Topical Drugs Market Trends And Strategies

4. Over The Counter (OTC) Topical Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Over The Counter (OTC) Topical Drugs Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Over The Counter (OTC) Topical Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Over The Counter (OTC) Topical Drugs Market Growth Rate Analysis
  • 5.4. Global Over The Counter (OTC) Topical Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Over The Counter (OTC) Topical Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Over The Counter (OTC) Topical Drugs Total Addressable Market (TAM)

6. Over The Counter (OTC) Topical Drugs Market Segmentation

  • 6.1. Global Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analgesics
  • Antibiotics
  • Antifungal
  • Antipruritic (Anti-Itch)
  • Astringents
  • Other Drug Classes
  • 6.2. Global Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Relief
  • Skin Care
  • Wound Care
  • Other Applications
  • 6.3. Global Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • 6.4. Global Over The Counter (OTC) Topical Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Pediatrics
  • Geriatrics
  • 6.5. Global Over The Counter (OTC) Topical Drugs Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Counterirritants
  • Capsaicin-Based Creams
  • Lidocaine-Based Products
  • Trolamine Salicylate Formulations
  • Combination Analgesics
  • 6.6. Global Over The Counter (OTC) Topical Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacitracin-Based Ointments
  • Neomycin-Based Creams
  • Polymyxin B Combinations
  • Mupirocin OTC
  • Antiseptic-Antibiotic Combinations
  • 6.7. Global Over The Counter (OTC) Topical Drugs Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clotrimazole Creams
  • Miconazole Creams
  • Terbinafine Formulations
  • Tolnaftate-Based Products
  • Undecylenic Acid Topical Solutions
  • 6.8. Global Over The Counter (OTC) Topical Drugs Market, Sub-Segmentation Of Antipruritic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hydrocortisone Creams
  • Calamine Lotion
  • Diphenhydramine Topical Gels
  • Pramoxine-Based Formulations
  • Menthol OR Camphor Anti-Itch Lotions
  • 6.9. Global Over The Counter (OTC) Topical Drugs Market, Sub-Segmentation Of Astringents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Witch Hazel Solutions
  • Aluminum Acetate
  • Zinc Oxide Ointments
  • Tannic Acid Or Plant-Based Astringents
  • 6.10. Global Over The Counter (OTC) Topical Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acne Treatment Topicals
  • Antiviral Creams
  • Wound Healing Ointments
  • Moisturizing And Barrier Creams

7. Over The Counter (OTC) Topical Drugs Market Regional And Country Analysis

  • 7.1. Global Over The Counter (OTC) Topical Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Over The Counter (OTC) Topical Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Over The Counter (OTC) Topical Drugs Market

  • 8.1. Asia-Pacific Over The Counter (OTC) Topical Drugs Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Over The Counter (OTC) Topical Drugs Market

  • 9.1. China Over The Counter (OTC) Topical Drugs Market Overview
  • 9.2. China Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Over The Counter (OTC) Topical Drugs Market

  • 10.1. India Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Over The Counter (OTC) Topical Drugs Market

  • 11.1. Japan Over The Counter (OTC) Topical Drugs Market Overview
  • 11.2. Japan Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Over The Counter (OTC) Topical Drugs Market

  • 12.1. Australia Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Over The Counter (OTC) Topical Drugs Market

  • 13.1. Indonesia Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Over The Counter (OTC) Topical Drugs Market

  • 14.1. South Korea Over The Counter (OTC) Topical Drugs Market Overview
  • 14.2. South Korea Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Over The Counter (OTC) Topical Drugs Market

  • 15.1. Western Europe Over The Counter (OTC) Topical Drugs Market Overview
  • 15.2. Western Europe Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Over The Counter (OTC) Topical Drugs Market

  • 16.1. UK Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Over The Counter (OTC) Topical Drugs Market

  • 17.1. Germany Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Over The Counter (OTC) Topical Drugs Market

  • 18.1. France Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Over The Counter (OTC) Topical Drugs Market

  • 19.1. Italy Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Over The Counter (OTC) Topical Drugs Market

  • 20.1. Spain Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Over The Counter (OTC) Topical Drugs Market

  • 21.1. Eastern Europe Over The Counter (OTC) Topical Drugs Market Overview
  • 21.2. Eastern Europe Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Over The Counter (OTC) Topical Drugs Market

  • 22.1. Russia Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Over The Counter (OTC) Topical Drugs Market

  • 23.1. North America Over The Counter (OTC) Topical Drugs Market Overview
  • 23.2. North America Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Over The Counter (OTC) Topical Drugs Market

  • 24.1. USA Over The Counter (OTC) Topical Drugs Market Overview
  • 24.2. USA Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Over The Counter (OTC) Topical Drugs Market

  • 25.1. Canada Over The Counter (OTC) Topical Drugs Market Overview
  • 25.2. Canada Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Over The Counter (OTC) Topical Drugs Market

  • 26.1. South America Over The Counter (OTC) Topical Drugs Market Overview
  • 26.2. South America Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Over The Counter (OTC) Topical Drugs Market

  • 27.1. Brazil Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Over The Counter (OTC) Topical Drugs Market

  • 28.1. Middle East Over The Counter (OTC) Topical Drugs Market Overview
  • 28.2. Middle East Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Over The Counter (OTC) Topical Drugs Market

  • 29.1. Africa Over The Counter (OTC) Topical Drugs Market Overview
  • 29.2. Africa Over The Counter (OTC) Topical Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Over The Counter (OTC) Topical Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Over The Counter (OTC) Topical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Over The Counter (OTC) Topical Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Over The Counter (OTC) Topical Drugs Market Competitive Landscape
  • 30.2. Over The Counter (OTC) Topical Drugs Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. The Procter And Gamble Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Over The Counter (OTC) Topical Drugs Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. Novartis AG
  • 31.3. GSK plc
  • 31.4. 3M Company
  • 31.5. Sun Pharmaceutical Industries Ltd
  • 31.6. Perrigo Company plc
  • 31.7. Cipla Limited
  • 31.8. Zydus Cadila Healthcare Limited
  • 31.9. Glenmark Pharmaceuticals Limited
  • 31.10. Mankind Pharma Limited
  • 31.11. PL Developments Inc.
  • 31.12. Emami Limited
  • 31.13. LNK International Inc.
  • 31.14. Reckitt Benckiser Group plc
  • 31.15. Trillium Health Care Products Inc.

32. Global Over The Counter (OTC) Topical Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Over The Counter (OTC) Topical Drugs Market

34. Recent Developments In The Over The Counter (OTC) Topical Drugs Market

35. Over The Counter (OTC) Topical Drugs Market High Potential Countries, Segments and Strategies

  • 35.1 Over The Counter (OTC) Topical Drugs Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Over The Counter (OTC) Topical Drugs Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Over The Counter (OTC) Topical Drugs Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer